<DOC>
	<DOC>NCT00925223</DOC>
	<brief_summary>Brain-derived neurotrophic factor (BDNF), originally known to be a member of the nerve growth factor family, has aroused attention as a modulator in visceral hyperalgesia recently. Visceral hypersensitivity is recognized as a clinical hallmark in IBS patients. So in this study, the investigators will focus on the role of BDNF in colonic hyperalgesia in IBS patients.</brief_summary>
	<brief_title>Brain-derived Neurotrophic Factor Participates in Visceral Hyperalgesia in Irritable Bowel Syndrome (IBS) Patients</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Irritable Bowel Syndrome</mesh_term>
	<mesh_term>Hyperalgesia</mesh_term>
	<criteria>Patients diagnosed with irritable bowel syndrome. Patients have similar clinical symptoms as IBS, yet there is morphologic changes in the intestine.</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>IBS</keyword>
	<keyword>BDNf</keyword>
	<keyword>visceral hypersensitivity</keyword>
</DOC>